Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

GSK Commences Phase 2 Study for Monoclonal Antibody

April 18, 2016 8:32 am | News | Comments

The goal is to evaluate the efficacy and safety profile of the drug in patients with inflammatory hand osteoarthritis. 

TOPICS:

Medical Pot Activists Fear Epilepsy Drug Could Undercut Them

April 18, 2016 8:28 am | by Julie Carr Smyth, Associated Press | News | Comments

An experimental epilepsy drug made from cannabis plants grown in England is complicating the medical marijuana debate in hospitals and statehouses.

TOPICS:

AACR: Breast Cancer Stem Cells May Reduce Diseases' Metastatic Potential

April 18, 2016 8:24 am | by University of Colorado | News | Comments

Stem-like breast cancer cells secrete molecules that allow neighboring, otherwise anchored cells to metastasize.

TOPICS:
Advertisement

Top Republicans: Zika Funding Likely But Timing Uncertain

April 17, 2016 11:15 am | by Andrew Taylor, Associated Press | News | Comments

Another senior Republican said additional Zika money most likely wouldn't come before September at the earliest.

TOPICS:

Report: First Diagnosed Case of Alzheimer's Disease in HIV-Positive Individual

April 17, 2016 10:30 am | by Georgetown University Medical Center | News | Comments

Diagnosis of dementia in older HIV-infected individuals is on the rise.

Implantable Device Targets Pancreatic Cancer

April 16, 2016 11:30 am | by Anne Trafton, MIT News Office | News | Comments

Pancreatic cancer is the third leading cause of cancer deaths in the United States.

TOPICS:

Weighing Coffee's Health Benefits

April 15, 2016 3:02 pm | by Colorado State University | News | Comments

Chances are, you or someone you know is a coffee drinker. 

TOPICS:

Testing Diabetes Dosage

April 15, 2016 3:02 pm | by Northwestern University | News | Comments

A recent study investigated whether a higher dose of liraglutide may lead to greater weight loss. 

TOPICS:
Advertisement

Allergen Immunotherapy Poses No Infection Risk

April 15, 2016 2:49 pm | by Massachusetts General Hospital | News | Comments

The current study was prepared to provide data supporting the response to the proposed changes from several allergy and immunology specialty organizations.

TOPICS:

Drug Discovery Spotlight: Frightening Zika Images; Valeant's Dysfunction; Reclassifying a Tumor

April 15, 2016 11:17 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight — we’ve rounded up this week’s top news, trending headlines, and all-around interesting reads.

TOPICS:

Poor Patient Warfarin Knowledge May Increase Side Effects Risk

April 15, 2016 10:13 am | by European Society of Cardiology | News | Comments

Patients have poor knowledge of warfarin which may increase their risk of serious side effects, according to research presented today at EuroHeartCare 2016.

TOPICS:

Troubles Mount for Theranos, Feds Threaten Sanctions

April 15, 2016 9:55 am | by Seth Augenstein, Digital Reporter | News | Comments

Scientific and regulatory troubles continue to mount for Theranos, the much-touted blood-testing startup.

TOPICS:

New Tests for Choosing Right Hep C Drug Could Save Money

April 15, 2016 8:52 am | by Linda A. Johnson, AP Business Writer | News | Comments

New tests designed to help doctors pick the right hepatitis C medicine for patients could mean faster cures and lower costs.

TOPICS:

Coffee Consumption Linked to Lower Colon Cancer Risk

April 15, 2016 8:46 am | by USC | News | Comments

The indication of decreased risk was seen across all types of coffee, both caffeinated and decaffeinated.

Vitamin D Helps Reduce Childhood Allergy Rate

April 15, 2016 8:45 am | by University of Auckland | News | Comments

Vitamin D supplements during pregnancy and infancy may help to reduce New Zealand’s high childhood allergy rate.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading